DUE: September 5, 2024
Advancing the development of diagnostic and prevention tools or treatments for musculoskeletal, rheumatic, or skin diseases.
Late-Stage Translation of Biomedical and Behavioral Research Results in Arthritis and Musculoskeletal and Skin Diseases from Academic/Non-profit Lab to Marketplace (SBIR [R43/R44] Clinical Trial Not Allowed)